SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-042231
Filing Date
2018-08-07
Accepted
2018-08-07 07:31:31
Documents
60
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv499024_10q.htm 10-Q 491955
2 EXHIBIT 10.1 tv499024_ex10-1.htm EX-10.1 123783
3 EXHIBIT 31.1 tv499024_ex31-1.htm EX-31.1 9827
4 EXHIBIT 31.2 tv499024_ex31-2.htm EX-31.2 9765
5 EXHIBIT 32.1 tv499024_ex32-1.htm EX-32.1 3484
6 EXHIBIT 32.2 tv499024_ex32-2.htm EX-32.2 3557
  Complete submission text file 0001144204-18-042231.txt   4486346

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT lpcn-20180630.xml EX-101.INS 1163176
8 XBRL TAXONOMY EXTENSION SCHEMA lpcn-20180630.xsd EX-101.SCH 28667
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lpcn-20180630_cal.xml EX-101.CAL 34756
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lpcn-20180630_def.xml EX-101.DEF 223580
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE lpcn-20180630_lab.xml EX-101.LAB 262202
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lpcn-20180630_pre.xml EX-101.PRE 253931
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36357 | Film No.: 18996290
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences